» Authors » Ali Basil Ali

Ali Basil Ali

Explore the profile of Ali Basil Ali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 149
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh N, Santos T, Ali A, Khan H, Kibrik P, Storch J, et al.
Vascular . 2024 Aug; :17085381241273211. PMID: 39120517
Objective: Previous randomized prospective trials have demonstrated the effectiveness of transcatheter tissue plasminogen activator (tPA) thrombolysis in treating acute limb ischemia (ALI) compared to conventional surgery. These pivotal trials have...
2.
Kibrik P, Ali A, Chait J, Arustamyan M, Khan H, Mazurovsky S, et al.
J Vasc Surg Venous Lymphat Disord . 2023 Sep; 12(1):101672. PMID: 37678668
Background: Endovenous thermal ablation (EVTA) of the lower extremity veins has risen to become the main treatment modality for symptomatic venous reflux disease. One of the main reported side effects...
3.
Ali A, Mansoor T, Al-Jasim A, Aly S, Naughton P, Moneley D, et al.
Ir J Med Sci . 2022 Nov; 192(4):1825. PMID: 36385697
No abstract available.
4.
Reilly A, Khawaja A, Ali A, Madsen T, Molino-Bacic J, Heffernan D, et al.
World Neurosurg . 2022 Oct; 169:e16-e28. PMID: 36202343
Objective: Decompressive craniectomy is recommended to reduce mortality in severe traumatic brain injury (TBI). Disparities exist in TBI treatment outcomes; however, data on disparities pertaining to decompressive craniectomy utilization is...
5.
Ali A, Khawaja A, Reilly A, Tahir Z, Rao S, Bernstock J, et al.
World Neurosurg . 2022 Feb; 161:e531-e545. PMID: 35196589
Objective: Traumatic brain injury (TBI) is a risk factor for venous thromboembolism (VTE). The risk of VTE after decompressive craniectomy (DC) and its effects on the outcomes are unknown. We...
6.
Reilly A, Ali A, Skally M, Gaughan L, Hamilton V, Troy A, et al.
Ir J Med Sci . 2020 Sep; 190(2):763-769. PMID: 32978638
Background: The true incidence of sepsis in surgical cohorts in Ireland remains unclear. According to inpatient audits, patients in surgical diagnostic groups (DRG) who developed sepsis had a longer length...
7.
Rubin D, Jarrah A, Li K, LaRose S, Monk A, Ali A, et al.
JAMA Neurol . 2020 Aug; 77(12):1536-1542. PMID: 32777012
Importance: Chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory hematologic malignant neoplasm causes severe neurologic adverse events ranging from encephalopathy and aphasia to cerebral edema and death. The...
8.
Rubin D, Danish H, Ali A, Li K, LaRose S, Monk A, et al.
Brain . 2019 Mar; 142(5):1334-1348. PMID: 30891590
Chimeric antigen receptor T cell therapy has become an important tool in the treatment of relapsed and refractory malignancy; however, it is associated with significant neurological toxicity. We characterized the...